Alliance Pharmaceutical Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alliance Pharmaceutical

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John R Resseger who wrote (218)	3/26/1998 6:13:00 AM
From: Bob Barels	Read Replies (1) of 548

Contamination had to do with OXYGENT in the early 90's and not with LIQUIVENT. The ALLP site started in 1997 so the contamination is old news. Only people who have followed the stock since back then would know. IMO, that this was one of the main reasons that the first German company terminated their collaboration. It showed them how good ALLP's science was. The market for IMAGENT is not significant so even if it gets approved no big deal. Yes, I agree that ALLP may be on the way to $100 but to the power of zero (for those who know a little math). By the way, it's losing ground every day. I guess it went up because of the San Diego Conference (emerging growth companies etc.), but Duane Roth did not impress anybody (every year they are presenting the same things using words like promising, huge market potential, encouraging results and no new progress). I am looking at $6 before J&J drops them and at $2-3 when the news will be out: "NO MORE MILESTONE PAYMENTS"

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next